IAIM
LTRN icon

International Assets Investment Management’s Lantern Pharma LTRN Stock Holding History

International Assets Investment Management’s Portfolio LTRN Stock Details LTRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-900
Closed -$17K – 1281
2021
Q1 		$17K Hold
900
– – ﹤0.01% 1363
2020
Q4 		$17K Buy
+900
New +$15.5K ﹤0.01% 1232

Other funds holding LTRN

CA
Corriente Advisors Fort Worth, Texas $9.53M AUM 805.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RAM
Redmond Asset Management Henrico, Virginia $366M AUM 10.64% 1-Year Est. Return
WWM
Wolff Wiese Magana Carslbad, California $217M AUM 47.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

International Assets Investment Management's LTRN Position: Q2 2021 in Review

International Assets Investment Management sold out of Lantern Pharma (LTRN) in Q2 2021, closing a stake of 900 shares — an estimated $17K sold.

International Assets Investment Management first reported a position in LTRN in Q4 2020 and held it in 2 quarters. The position peaked at $17K in Q1 2021. 22 funds tracked by Wall St. Rank hold LTRN as of Q2 2021.

  • International Assets Investment Management reported no remaining Lantern Pharma position as of Q2 2021 after selling out during the quarter.
  • International Assets Investment Management sold 900 Lantern Pharma shares in Q2 2021, an estimated $17K.
  • International Assets Investment Management first reported a position in Lantern Pharma in Q4 2020 and held it in 2 quarters.
  • International Assets Investment Management's Lantern Pharma position peaked at $17K in Q1 2021.
  • 22 funds tracked by Wall St. Rank held Lantern Pharma as of Q2 2021.

Based on International Assets Investment Management's 13F filing for Q2 2021, filed 14 Jul 2021.